Tildrakizumab efficacy for psoriatic arthritis: 24-week analysis of swollen and tender joint counts and pain

被引:0
|
作者
Espinoza, Luis R. [1 ]
Ballerini, Rocco [2 ]
Chou, Richard [3 ]
Rozzo, Stephen J. [4 ]
Mendelsohn, Alan M. [4 ]
机构
[1] Louisiana State Univ, Rheumatol Sect, Hlth Sci Ctr, New Orleans, LA USA
[2] Sun Pharma Adv Res Co Ltd, Mumbai, Maharashtra, India
[3] SUNY Buffalo, Buffalo, NY USA
[4] Sun Pharma, Mumbai, Maharashtra, India
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
15994
引用
收藏
页码:AB166 / AB166
页数:1
相关论文
共 50 条
  • [21] Apremilast, An Oral Phosphodiesterase 4 Inhibitor, Is Associated With Long-Term (52-Week) Improvement In Tender and Swollen Joint Counts In Patients With Psoriatic Arthritis: Results From Three Phase 3, Randomized, Controlled Trials
    Cutolo, Maurizio
    Mease, Philip J.
    Gladman, Dafna D.
    Kavanaugh, Arthur
    Adebajo, Adewale O.
    Gomez-Reino, Juan J.
    Wollenhaupt, Juergen
    Schett, Georg
    Lespessailles, Eric
    Shah, Kamal
    Hu, ChiaChi
    Stevens, Randall M.
    Edwards, Christopher J.
    Birbara, Charles A.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S135 - S136
  • [22] MULTICENTER 24-WEEK STUDY TO ASSESS THE EFFICACY AND SAFETY OF TACROLIMUS IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
    Hur, J.
    Hong, S.
    Kim, S.
    Kim, G.
    Choi, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1404 - 1404
  • [23] COST PER RESPONDER ANALYSIS FOLLOWING A 24-WEEK PSORIATIC ARTHRITIS TREATMENT WITH SECUKINUMAB VERSUS ETANERCEPT FROM THE PORTUGUESE PAYER PERSPECTIVE
    Silva, C.
    Esparteiro, J.
    Fonseca, A.
    Laires, P. A.
    VALUE IN HEALTH, 2018, 21 : S296 - S296
  • [24] Tildrakizumab Efficacy on Psoriasis in Patients with Psoriatic Arthritis-An Analysis from a Phase 2 Study
    Gottlieb, Alice
    Orbai, Ana-Maria
    Ballerini, Rocco
    Chou, Richard C.
    Rozzo, Stephen
    Mendelsohn, Alan
    Espinoza, Luis R.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [25] Tildrakizumab efficacy on psoriasis in patients with psoriatic arthritis-an analysis from a phase 2 study
    Gottlieb, A. B.
    Ballerini, R.
    Chou, R. C.
    Rozzo, S. J.
    Rozzo, S.
    Espinoza, L. R.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 44 - 44
  • [26] Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 1 trial
    Kristensen, Lars Erik
    Keiserman, Mauro
    Papp, Kim
    McCasland, Leslie
    White, Douglas
    Lu, Wenjing
    Wang, Zailong
    Soliman, Ahmed M.
    Eldred, Ann
    Barcomb, Lisa
    Behrens, Frank
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (02) : 225 - 231
  • [27] Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial
    Ostor, Andrew
    Van den Bosch, Filip
    Papp, Kim
    Asnal, Cecilia
    Blanco, Ricardo
    Aelion, Jacob
    Alperovich, Gabriela
    Lu, Wenjing
    Wang, Zailong
    Soliman, Ahmed M.
    Eldred, Ann
    Barcomb, Lisa
    Kivitz, Alan
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (03) : 351 - 358
  • [28] Real-world Efficacy of Anti-TNF in Psoriatic Arthritis Patients with Enthesitis and Correlation of Enthesitis with Tender / Swollen Joints
    Starr, Michael
    Teo, Michelle
    Fortin, Isabelle
    Reis, Jodie
    Rahman, Proton
    Arendse, Regan
    Rampakakis, Emmanouil.
    Psaradellis, Eliotolisti
    Nantel, Francois
    Lehman, Allen
    Maslova, Karina
    Osborne, Brendan
    Tkaczyk, Cathy
    JOURNAL OF RHEUMATOLOGY, 2017, 44 (06) : 917 - 917
  • [29] Swollen to Tender Joint Count Ratio: A Novel Combination of Routine Measures to Assess Pain and Treatment Response in Rheumatoid Arthritis
    Lee, Yvonne C.
    ARTHRITIS CARE & RESEARCH, 2014, 66 (02) : 171 - 172
  • [30] Intravenous Golimumab in Adult Patients with Active Psoriatic Arthritis: Efficacy and Safety through Week 24
    Kavanaugh, Arthur
    Husni, M. Elaine
    Harrison, Diane D.
    Kim, Lilianne
    Lo, Kim Hung
    Hsia, Elizabeth C.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69